Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1993 Mar;91(3):429–436. doi: 10.1111/j.1365-2249.1993.tb05920.x

Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease; a prospective study.

K Morris 1, C Mohan 1, P L Wahi 1, I S Anand 1, N K Ganguly 1
PMCID: PMC1554714  PMID: 8095193

Abstract

In a prospective study, patients with quiescent rheumatic heart disease (CRHD), streptococcal pharyngitis (SP) and healthy normal subjects produced comparable amounts of IL-1 and IL-2, but acute rheumatic fever (ARF) patients produced significantly elevated amounts of IL-1 and IL-2 at all intervals up to 48 weeks. In active rheumatic heart disease (ARHD), IL-1 activity returned to within normal range at 48 weeks, but IL-2 activity remained persistently elevated compared with CRHD, SP and healthy age- and sex-matched volunteers. CD4+ T lymphocytes were significantly increased in the peripheral blood of ARF and ARHD patients. The amount of IL-2 produced by ARF and ARHD patients correlated with the percentage of helper T lymphocytes (CD4+ cells) but not with the percentage of suppressor/cytotoxic T lymphocytes (CD8+ cells). Moreover, pre- and post-phytohaemagglutinin (PHA)-stimulated peripheral blood mononuclear cell (PBMC) cultures from ARF and ARHD patients contained higher proportions of IL-2R+ (CD25+) cells than those from patients with SP, CRHD and normal individuals, which persisted up to 48 weeks. The percentage of CD25+ cells in both types of PBMC cultures directly correlated with the percentage of CD4+ cells and not with CD8+ cells in active rheumatic patients only. These findings indicate that the immune response in ARF and ARHD patients is skewed to produce activated helper T cells that release IL-2 which drives the accumulation of more T helper cells. The result is an undamped helper T cell response in the peripheral blood of these patients.

Full text

PDF
429

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acuto O., Fabbi M., Bensussan A., Milanese C., Campen T. J., Royer H. D., Reinherz E. L. The human T-cell receptor. J Clin Immunol. 1985 May;5(3):141–157. doi: 10.1007/BF00915505. [DOI] [PubMed] [Google Scholar]
  2. Agrawal B. V., Gupta R. M., Singh V. P., Somani P. N. Serum immunoglobulins in rheumatic heart disease. Indian J Med Res. 1975 Apr;63(4):570–575. [PubMed] [Google Scholar]
  3. Arend W. P., Massoni R. J. The effect of complement in adherent immune complexes on Fc and C3 receptor expression in human monocytes. Immunology. 1981 Dec;44(4):717–725. [PMC free article] [PubMed] [Google Scholar]
  4. Bhatia R., Narula J., Reddy K. S., Koicha M., Malaviya A. N., Pothineni R. B., Tandon R., Bhatia M. L. Lymphocyte subsets in acute rheumatic fever and rheumatic heart disease. Clin Cardiol. 1989 Jan;12(1):34–38. doi: 10.1002/clc.4960120106. [DOI] [PubMed] [Google Scholar]
  5. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  6. Dinarello C. A. An update on human interleukin-1: from molecular biology to clinical relevance. J Clin Immunol. 1985 Sep;5(5):287–297. doi: 10.1007/BF00918247. [DOI] [PubMed] [Google Scholar]
  7. Erber W. N., Pinching A. J., Mason D. Y. Immunocytochemical detection of T and B cell populations in routine blood smears. Lancet. 1984 May 12;1(8385):1042–1046. doi: 10.1016/s0140-6736(84)91451-x. [DOI] [PubMed] [Google Scholar]
  8. Gowrishankar R., Agarwal S. C. Leucocyte migration inhibition with human heart valve glycoproteins and group A streptococcal ribonucleic acid proteins in rheumatic heart disease and post-streptococcal glomerulonephritis. Clin Exp Immunol. 1980 Feb;39(2):519–525. [PMC free article] [PubMed] [Google Scholar]
  9. Helminen M., Vesikari T. Spontaneous and inducible interleukin 1 production from peripheral blood monocytes in bacterial and viral infections in children. Pediatr Infect Dis J. 1987 Dec;6(12):1102–1106. [PubMed] [Google Scholar]
  10. Hsieh K. H., Lue H. C. Immunoregulation in rheumatic fever. Asian Pac J Allergy Immunol. 1985 Jun;3(1):23–29. [PubMed] [Google Scholar]
  11. Kemeny E., Grieve T., Marcus R., Sareli P., Zabriskie J. B. Identification of mononuclear cells and T cell subsets in rheumatic valvulitis. Clin Immunol Immunopathol. 1989 Aug;52(2):225–237. doi: 10.1016/0090-1229(89)90174-8. [DOI] [PubMed] [Google Scholar]
  12. Kodama I., Honjo H., Kamiya K., Toyama J. Two types of sodium channel block by class-I antiarrhythmic drugs studied by using Vmax of action potential in single ventricular myocytes. J Mol Cell Cardiol. 1990 Jan;22(1):1–12. doi: 10.1016/0022-2828(90)90967-7. [DOI] [PubMed] [Google Scholar]
  13. Leonard W. J., Depper J. M., Uchiyama T., Smith K. A., Waldmann T. A., Greene W. C. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature. 1982 Nov 18;300(5889):267–269. doi: 10.1038/300267a0. [DOI] [PubMed] [Google Scholar]
  14. Levy R., Kotb M., Nagauker O., Majumdar G., Alkan M., Ofek I., Beachey E. H. Stimulation of oxidative burst in human monocytes by lipoteichoic acids. Infect Immun. 1990 Feb;58(2):566–568. doi: 10.1128/iai.58.2.566-568.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Luger T. A., Smolen J. S., Chused T. M., Steinberg A. D., Oppenheim J. J. Human lymphocytes with either the OKT4 or OKT8 phenotype produce interleukin 2 in culture. J Clin Invest. 1982 Aug;70(2):470–473. doi: 10.1172/JCI110637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ming R. H., Atluru D., Spellman C. W., Imir T., Goodwin J. S., Strickland R. G. Peripheral blood mononuclear-cell interleukin-2 production, receptor generation and lymphokine-activated cytotoxicity in inflammatory bowel disease. J Clin Immunol. 1987 Jan;7(1):59–63. doi: 10.1007/BF00915426. [DOI] [PubMed] [Google Scholar]
  17. Mizel S. B., Oppenheim J. J., Rosenstreich D. L. Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes. J Immunol. 1978 May;120(5):1497–1503. [PubMed] [Google Scholar]
  18. Read S. E., Reid H. F., Fischetti V. A., Poon-King T., Ramkissoon R., McDowell M., Zabriskie J. B. Serial studies on the cellular immune response to streptococcal antigens in acute and convalescent rheumatic fever patients in Trinidad. J Clin Immunol. 1986 Nov;6(6):433–441. doi: 10.1007/BF00915249. [DOI] [PubMed] [Google Scholar]
  19. Read S. E., Reid H. F., Fischetti V. A., Poon-King T., Ramkissoon R., McDowell M., Zabriskie J. B. Serial studies on the cellular immune response to streptococcal antigens in acute and convalescent rheumatic fever patients in Trinidad. J Clin Immunol. 1986 Nov;6(6):433–441. doi: 10.1007/BF00915249. [DOI] [PubMed] [Google Scholar]
  20. Ruscetti F. W., Gallo R. C. Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes. Blood. 1981 Mar;57(3):379–394. [PubMed] [Google Scholar]
  21. Solbach W., Barth S., Röllinghoff M., Wagner H. Interactions of human T cell subsets during the induction of cytotoxic T lymphocytes: the role of interleukins. Clin Exp Immunol. 1982 Jul;49(1):167–175. [PMC free article] [PubMed] [Google Scholar]
  22. Zabriskie J. B. Rheumatic fever: the interplay between host, genetics, and microbe. Lewis A. Conner memorial lecture. Circulation. 1985 Jun;71(6):1077–1086. doi: 10.1161/01.cir.71.6.1077. [DOI] [PubMed] [Google Scholar]
  23. van de Rijn I., Zabriskie J. B., McCarty M. Group A streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen. J Exp Med. 1977 Aug 1;146(2):579–599. doi: 10.1084/jem.146.2.579. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES